The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.
New York University Medical Center, NY, USA.
J A
JA
Carucci
K
K
Washenik
A
A
Weinstein
J
J
Shupack
D E
DE
Cohen
D000328:Adult; D000368:Aged; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists; D008297:Male; D008875:Middle Aged; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D018927:Anti-Asthmatic Agents; D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds; C062735:zafirlukast